Owkin Inc - Company Profile
Powered by 
All the sales intelligence you need on Owkin Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Owkin Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Owkin Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Owkin Inc (Owkin) is a life science technology company that offers artificial intelligence and machine learning solutions for developing medicines, discovering new treatments, drugs and disease remedies. The company’s services include drug discovery, clinical development and diagnostics. It develops federated learning solutions for medical research activities. The company utilizes MSIntuit CRC, a CE-marked artificial intelligence (AI) diagnostic, that optimizes microsatellite instability (MSI) testing for colorectal cancer and RlapsRisk BC that helps in the treatment for early breast cancer patients. It serves biotechnology, medical research, pharmaceutical and other industries. Owkin is headquartered in New York City, New York, the US.
Products and Services
| Services | Brands |
|---|---|
| Drug Discovery | MSIntuit |
| Diagnostics | RlapsRisk |
| Clinical Development |
Competitor Comparison
| Key Parameters | Owkin Inc | Madrigal Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | Allerin Tech Pvt Ltd | Genfit Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | New York City | West Conshohocken | Foster City | - | Cambridge |
| State/Province | New York | Pennsylvania | California | - | Massachusetts |
| No. of Employees | 350 | 915 | 322 | - | - |
| Entity Type | Private | Public | Public | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jean Jacques Bienaime | Chairman | Executive Board | 2024 | - |
| Thomas Clozel, MD | Chief Executive Officer; Director | Executive Board | - | - |
| Graeme Bell | Chief Financial Officer | Senior Management | 2025 | - |
| Alban de la Sabliere | Chief Operating Officer | Senior Management | - | - |
| Rodrigo Barnes | Chief Technology Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer